NCT03307577View on ClinicalTrials.gov

A Phase 2 Safety and Efficacy Study of UHE-101 Cream in Subjects With Acne Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 5, 2017

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Acne Vulgaris
Interventions
DRUG

UHE-101 Cream

Topical cream containing investigational drug at a concentration of 1%

OTHER

Vehicle Cream

Topical cream containing no drug (i.e., placebo)

Trial Locations (1)

92123

Site 02, San Diego

All Listed Sponsors
lead

Therapeutics, Inc.

INDUSTRY

NCT03307577 - A Phase 2 Safety and Efficacy Study of UHE-101 Cream in Subjects With Acne Vulgaris | Biotech Hunter | Biotech Hunter